First Cell Painting Kit introduced by PerkinElmer
- Post By :
- Source: PerkinElmer
- Date: 06 Mar,2021
This new range of reagents leverages PerkinElmer’s experience in cellular imaging and high-content screening and operates alongside the business’s microplates, automation, software and industry-leading high-content screening instruments. With this entire screening workflow, researchers can better understand disease and create more pinpointed therapies and drugs to treat them.
Cell painting is a strong program of high-content screening technology that combines cell and computational biology to study the effects of perturbagens like chemical compounds, genes or drugs on the behavior of cells. Cells are”painted” by labelling cellular compartments with distinct fluorescent bioprobes to allow those areas to be quantitatively profiled. However, preparing reagents from scratch can be incredibly time consuming.
“Researchers are using high-content screening and cell painting to make extraordinary discoveries that will help drive more innovative drugs and therapies,” said Alan Fletcher, Vice President and GM of Life Sciences, PerkinElmer. “With the addition of our new PhenoVue™ cellular imaging reagents, we now offer a complete suite of high-content screening products and expert services. This will help researchers build more streamlined workflows and enjoy the convenience of working with a single, expert technology provider helping to accelerate discovery.”
For more information: Click here
PerkinElmer enables scientists, researchers and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, we deliver unique solutions to serve the diagnostics, life sciences, food and applied markets. We strategically partner with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Our dedicated team of about 14,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $3.8 billion in 2020, serves customers in 190 countries, and is a component of the S&P 500 index.